ClinicalTrials.Veeva

Menu

Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

BioMarin Pharmaceutical logo

BioMarin Pharmaceutical

Status

Unknown

Conditions

Rare Genetic Disorders

Study type

Observational

Funder types

Industry

Identifiers

NCT02365376
BMN 000-901

Details and patient eligibility

About

The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Willing and able to provide written, signed informed consent
  • Willing and able to comply with all study procedures

Exclusion criteria

  • Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study
  • Concurrent disease or condition that would interfere with study participation or safety.

Trial contacts and locations

1

Loading...

Central trial contact

Evelyn Wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems